Key result
Stent-assisted coil embolization using only tirofiban for ruptured wide-necked aneurysms achieved complete occlusion in 29 of 50 patients, with 10% asymptomatic stent thrombosis and 8% mortality.
Why the study?
Is stent-assisted coil embolization using only tirofiban safe and effective for ruptured wide-necked intracranial aneurysms?
Observational (n=50)
Is stent-assisted coil embolization using only tirofiban safe and effective for ruptured wide-necked intracranial aneurysms?
Stent-assisted coil embolization using only tirofiban appears relatively safe and efficient for treating ruptured wide-necked intracranial aneurysms.
Answers are grounded in this paper and cite their sources.
May support tirofiban monotherapy feasibility; leaves open need for RCTs before practice change.
OBJECTIVE: The aim of this study was to evaluate the safety and efficacy of stent-assisted coil embolization using only a glycoprotein IIb/IIIa inhibitor (tirofiban). MATERIALS AND METHODS: We retrospectively reviewed patients with a subarachnoid hemorrhage due to ruptured wide-necked intracranial aneurysms who were treated by stent-assisted coil embolization. In all patients, the glycoprotein IIb/IIIa inhibitor tirofiban was administered just before stent deployment. Electronic medical records for these patients were reviewed for peri-procedural complications and extra-ventricular drainage catheter related hemorrhage, as well as Glasgow outcome scale (GOS) at discharge, 3 months, and 6 months follow-up were recorded. RESULTS: Fifty-one aneurysms in 50 patients were treated. The mean patient age was 64.9 years. Eighteen patients (36%) received a World Federation of Neurosurgical Societies grade of 4 or 5. The mean aneurysm size was 9.48 mm and mean dome-to-neck ratio was 1.06. No intraoperative aneurysm ruptures occurred, although five (10%) episodes of asymptomatic stent thrombosis did occur. Three patients experienced a delayed thrombo-embolic event and two a delayed hemorrhagic event. Immediate radiologic assessment indicated a complete occlusion in 29 patients, a residual neck in 19, and a residual sac in 3. Four patients (8%) died. Sixteen patients (32%) experienced a poor GOS (< 4). Two aneurysms were recanalized during the follow-up period (mean, 19 months for clinical and 18 months for angiographic follow-up). CONCLUSION: Treatment of ruptured wide-necked intracranial aneurysms via stent-assisted coil embolization with a glycoprotein IIb/IIIa inhibitor alone was found to be relatively safe and efficient.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2018) conducted an observational in Subarachnoid hemorrhage due to ruptured wide-necked intracranial aneurysms (n=50). Stent-assisted coil embolization using only tirofiban was evaluated on Safety and efficacy (peri-procedural complications, hemorrhage, Glasgow outcome scale, and occlusion rate). Stent-assisted coil embolization using only tirofiban for ruptured wide-necked aneurysms achieved complete occlusion in 29 of 50 patients, with 10% asymptomatic stent thrombosis and 8% mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: